Skip to Main ContentSkip to FooterSkip to Search
  1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Drug Substance Manufacturing
  6.  » GPEx® Lightning: Achieving Rapid, High-Titer Expression for Next-Generation Biologics

GPEx® Lightning: Achieving Rapid, High-Titer Expression for Next-Generation Biologics

Summary: In this webinar learn how the GPEx® Lightning platform accelerates the high-titer production of next-generation multispecific antibodies and complex protein biologics with unmatched speed, flexibility and scalability. In this webinar, gain insights into how GPEx® Lightning improves production efficiency, reduces the development and production timeline, making it ideal for commercial manufacturing. Additionally, learn about its tunable expression capabilities, which ensure balanced multi-gene or multi-chain expression, particularly for complex and hard-to-express proteins, while maintaining consistent quality. Explore how GPEx® Lightning’s flexibility supports innovation in next-generation biologics development and learn how your team can leverage its unique advantages for commercial success.

Click here to view the Webinar